Ossification, Heterotopic
"Ossification, Heterotopic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The development of bony substance in normally soft structures.
Concept/Terms
Ossification, Heterotopic- Ossification, Heterotopic
- Heterotopic Ossification
- Ossification, Pathological
- Pathological Ossification
- Ossification, Pathologic
- Pathologic Ossification
- Ossification, Ectopic
- Ectopic Ossification
Below are MeSH descriptors whose meaning is more general than "Ossification, Heterotopic".
Below are MeSH descriptors whose meaning is more specific than "Ossification, Heterotopic".
This graph shows the total number of publications written about "Ossification, Heterotopic" by people in Harvard Catalyst Profiles by year, and whether "Ossification, Heterotopic" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 1 | 2 |
| 1993 | 1 | 1 | 2 |
| 1994 | 1 | 2 | 3 |
| 1995 | 2 | 2 | 4 |
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 2 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 1 | 3 |
| 2001 | 3 | 2 | 5 |
| 2002 | 3 | 1 | 4 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 4 | 2 | 6 |
| 2008 | 2 | 0 | 2 |
| 2009 | 3 | 0 | 3 |
| 2010 | 3 | 1 | 4 |
| 2011 | 4 | 1 | 5 |
| 2012 | 4 | 0 | 4 |
| 2013 | 2 | 0 | 2 |
| 2014 | 5 | 3 | 8 |
| 2015 | 15 | 0 | 15 |
| 2016 | 11 | 2 | 13 |
| 2017 | 13 | 1 | 14 |
| 2018 | 8 | 1 | 9 |
| 2019 | 5 | 2 | 7 |
| 2020 | 8 | 2 | 10 |
| 2021 | 4 | 2 | 6 |
| 2022 | 7 | 1 | 8 |
Below are the most recent publications written about "Ossification, Heterotopic" by people in Profiles.
-
Macrophage TGF-ß signaling is critical for wound healing with heterotopic ossification after trauma. JCI Insight. 2022 10 24; 7(20).
-
Contemporary perspectives on heterotopic ossification. JCI Insight. 2022 07 22; 7(14).
-
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1. J Clin Invest. 2022 06 15; 132(12).
-
Protocol paper: a multi-center, double-blinded, randomized, 6-month, placebo-controlled study followed by 12-month open label extension to evaluate the safety and efficacy of Saracatinib in Fibrodysplasia Ossificans Progressiva (STOPFOP). BMC Musculoskelet Disord. 2022 Jun 01; 23(1):519.
-
Chronic oropharyngeal pain and medical nomadism in an Eagle's syndrome patient: a case report. J Med Case Rep. 2022 May 12; 16(1):201.
-
Are There Identifiable Risk Factors Associated With Heterotopic Ossification of the Temporomandibular Joint? J Oral Maxillofac Surg. 2022 08; 80(8):1318-1330.
-
Incidence and Risk Factors for Heterotopic Ossification in a Matched Cohort Adolescent Population Undergoing Hip Arthroscopy. J Pediatr Orthop. 2022 Apr 01; 42(4):e331-e335.
-
Association between obesity and ossification of spinal ligaments in 622 asymptomatic subjects: a cross-sectional study. J Bone Miner Metab. 2022 Mar; 40(2):337-347.
-
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop. Front Endocrinol (Lausanne). 2021; 12:732728.
-
Whole-body Computed Tomography Versus Dual Energy X-ray Absorptiometry for Assessing Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva. Calcif Tissue Int. 2021 12; 109(6):615-625.